Celldex Therapeutics Inc (CLDX) — Capital Reinvestment Ratio
Latest as of December 2008:
0.02x
Celldex Therapeutics Inc (CLDX) has a Capital Reinvestment Ratio of 0.02x as of December 2008, meaning it reinvests 0% of its operating cash flow ($1.29 Million) in capital expenditures ($26.75K). See CLDX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$1.29 Million
USD
Capital Expenditures
$26.75K
USD
Data as of
Dec 2008
Most recent filing
Celldex Therapeutics Inc Capital Reinvestment Ratio (2006–2008)
This chart tracks Celldex Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Celldex Therapeutics Inc (2006–2008)
Year-by-year Capital Reinvestment Ratio for Celldex Therapeutics Inc from 2006 to 2008. For live market cap and broader valuation context, see market cap of Celldex Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.07x | $18.28 Million | $1.30 Million | ▼ -79.3% |
| 2006 | 0.35x | $27.00 Million | $9.32 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow